Joyance 2

Joyance Partners, established in 2012 and headquartered in San Francisco, is a venture capital firm focusing on early-stage investments. It specializes in startups and emerging technologies that empower individuals to improve their health and well-being, with a particular interest in health tech and consumer sectors. The firm invests in companies that leverage science and technology to cultivate joy and enhance lives, targeting pre-seed to Series A rounds in the United States, Canada, and Europe.

Omar Al-Busaidi

Investment Partner and Venture Partner

Yang Chen

Investor

Jun Deng Ph.D

Investment Partner

Sonia Dewar

Investment Partner

Mike Edelhart

Managing Partner

Toshi Eguchi

Managing Director, Joyance Asia

Jim Louderback

Venture Partner

Hidenari Nakayama Ph.D

Venture Partner, Joyance Partners

Neal O'Hara

Venture Partner

Seth Rosenblatt

Venture Partner

Charles Smith

Venture Partner

Nobuhiro Takanuma

Partner, Joyance Partners

Neha Tanna

Venture Partner

Bradley Welch

Venture Partner

Past deals in Personal Health

Epicore Biosystems

Series B in 2025
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

Millie

Series A in 2025
Millie is an innovative maternity clinic designed to enhance the healthcare experience for expectant and new mothers. Founded by individuals with personal and professional experience in maternity care, the clinic offers a comprehensive range of services to support women throughout their maternal journey. Millie's platform includes remote health monitoring, home postpartum visits, and access to a dedicated application for parenthood support. Additionally, the clinic provides one-on-one doula coaching, ensuring that patients receive extensive care, expert guidance, and continuous support during and after pregnancy. Millie's focus on improving clinical outcomes and streamlining the healthcare experience distinguishes it in the maternity care sector.

Sunnyside

Series A in 2023
Sunnyside is a company that develops an alcohol tracking application aimed at helping individuals cultivate healthier drinking habits. The app provides users with a personalized plan tailored to their existing drinking behaviors and specific goals. It includes features such as daily text reminders to encourage users to monitor and limit their alcohol consumption. By utilizing this app, users can experience benefits such as reduced weekly alcohol intake, improved sleep quality, enhanced dietary choices, financial savings, and an overall increase in well-being.

Jude

Seed Round in 2023
Jude is a healthcare company focused on addressing bladder-related issues and raising awareness about incontinence. It provides a range of bladder care solutions, including access to medical specialists who offer advice through social media platforms, virtual workshops, and private chat sessions. In addition to educational resources, Jude supplies health products designed to help individuals understand their conditions and manage them effectively. By promoting open discussions and providing expert guidance, Jude aims to empower individuals to lead leak-free lives and break the stigma surrounding bladder health.

Alba Health

Pre Seed Round in 2023
Alba Health is a company focused on enhancing children's gut health through digital solutions and advanced microbiome testing. It offers an innovative stool test kit designed for easy use, allowing parents to analyze their child's gut microbiome in a certified laboratory. Upon completion of the analysis, detailed results are provided, which enable parents to collaborate with dieticians in formulating personalized action plans for their children's dietary and health needs. Additionally, Alba Health places significant emphasis on data privacy by anonymizing test results, which can contribute to broader discoveries that positively influence children's health outcomes. The company's overarching mission is to improve the health of future generations by leveraging artificial intelligence and microbiome science.

Cure Hydration

Series A in 2023
Cure is a VC-backed hydration brand based in New York City. We’re the only premium hydration brand with a science-backed formula, plant-based ingredients, no added sugar, and 4x the electrolytes of leading sports drinks. The product is based on the World Health Organization's formula for Oral Rehydration Solution that is proven to hydrate as effectively as an IV drip but, unlike other ORS products, the ingredients are non-GMO, sustainably sourced, and have no added sugar. Made with coconut water and pink Himalayan salt, Cure provides everything your body needs for daily hydration and nothing it doesn't. Cure is backed by a medical advisory board that includes Dr. Roshini Raj, Dr. Dana Cohen, and Brooke Alpert and is FSA/HSA Eligible. In just 4 years, Cure has expanded to over 13,000 retail stores nationwide including CVS, Walgreens, and Sprouts, and was named to the Inc. 5000 list of fastest-growing companies in America at #225 (#10 in Food and Beverage). Cure is a female-founded company, certified Plastic Neutral, and donates a serving for every purchase made to someone in need. Our investors include Lerer Hippeau, Valedor Partners, Rocana Ventures, Beliade, Silas Capital, Litani Ventures, Joyance Partners, Parallel Ventures, Great Oaks Venture Capital, Simple Food Ventures, Carly Strife (Founder of BARK), Kathleen King (Founder of Tate's Cookies), Philip Krim (CEO at Casper), Nick Green (CEO at Thrive Market), Nas, Andy Roddick and more.

Luna Daily

Seed Round in 2023
Luna Daily is a Femtech startup focused on empowering women to enhance their body care routines. The company manufactures microbiome-balancing intimate care products designed for various areas, including the head, vulva, knees, and toes. Utilizing mineral-rich thermal water, pre-biotic active plant-based blends, and vitamin complexes, Luna Daily's offerings aim to maintain a healthy pH microbiome while nourishing, softening, and hydrating the skin. Through high-quality products, the company strives to promote intimate wellness for women.

Epicore Biosystems

Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

Sigrid Therapeutics

Venture Round in 2021
Sigrid Therapeutics AB is a clinical-stage biotechnology company based in Stockholm, Sweden, focused on developing innovative therapeutic products aimed at preventing and treating lifestyle diseases. The company has created a novel materials platform designed to alter food digestion in the body. Its lead product is an ingested medical device intended to lower blood sugar levels in prediabetics, representing a new approach to managing chronic conditions related to modern lifestyles. By targeting the gut, Sigrid Therapeutics seeks to help individuals achieve weight loss and overall better health outcomes.

Ombre

Seed Round in 2021
Ombre is a company that specializes in microbiome testing, providing a testing kit that combines personalized probiotics with microbiome analysis. The company's offerings include subscription-based customized testing, which delivers science-backed probiotics tailored to individual needs. This approach aims to provide actionable insights for the prevention of chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By focusing on the root causes of gut health issues, Ombre enables customers to better understand and improve their microbiome, promoting overall wellness.

Expectful

Seed Round in 2021
Expectful is a digital health and wellness platform focused on supporting women throughout their reproductive journey, including preconception, pregnancy, and postpartum stages. The platform offers a range of resources such as guided meditations, mindfulness exercises, and expert advice tailored to the unique needs of expectant and new mothers. By providing a non-pharmacologic and accessible approach to mental health, Expectful aims to reduce prenatal and postpartum stress, enhancing the overall well-being of both mothers and infants. The app is designed to make meditation easy and effective, helping users navigate the physical, mental, and emotional challenges associated with motherhood.

SkillYoga

Convertible Note in 2020
SkillYoga UG, established in 2018 and based in Berlin, Germany, specializes in providing online yoga classes tailored specifically for men. The company has developed a mobile health and fitness platform that offers a comprehensive online training system, featuring instructional videos on yoga and other fitness programs. This platform includes personalized training plans and a real-time progress tracker, allowing users to monitor their development daily. By offering a vast library of workouts created by professionals, SkillYoga aims to enhance users' functional strength, mobility, flexibility, and mindfulness. Additionally, it provides fitness enthusiasts with valuable health and fitness tips from industry experts.

Attn: Grace

Pre Seed Round in 2020
Attn: Grace, Inc. is a company dedicated to manufacturing and selling wellness products specifically for women's hygiene, focusing on urinary incontinence care. Established in 2017 and based in Cambridge, Massachusetts, the company offers a range of products, including pads, briefs, liners, and wipes. Attn: Grace distinguishes itself by utilizing innovative, plant-based materials derived from sugarcane waste, ensuring that its products are both effective and skin-safe. The company is committed to addressing the stigma surrounding urinary incontinence, providing reliable information and support for women facing this condition. By combining cutting-edge technology with an emphasis on health and wellbeing, Attn: Grace aims to deliver high-performance hygiene solutions that cater to the needs of women experiencing bladder leakage.

Pollie

Seed Round in 2020
Pollie is a healthcare technology company that operates an online teleconsultation platform focused on improving the patient experience for women dealing with complex chronic conditions related to hormonal imbalances. The platform connects users with independent specialists, facilitating communication about topics such as acne, hair loss, fatigue, and mood disorders. Pollie's business model streamlines this process by matching patients with doctors who align with their specific needs, helping both parties grow more efficiently.

Rosy Wellness

Pre Seed Round in 2020
Rosy Wellness, Inc. is a company focused on sexual health and wellness for women, founded in 2018 and based in Dallas, Texas. It has developed an app-based platform that addresses decreased sexual desire by offering a comprehensive range of resources. The application includes educational videos, sexual health assessments, and a customizable library of romantic and sexy stories. Additionally, it features guided sessions with psychologists designed to help women explore and enhance their sexual wellness at their own pace. By providing a personalized wellness plan that incorporates evidence-based practices, Rosy Wellness aims to empower women to achieve their unique sexual health goals.

Digbi Health

Convertible Note in 2020
Digbi Health, LLC, headquartered in Mountain View, California with offices in Bengaluru, India and Taguig, Philippines, specializes in digital therapeutics for chronic health conditions. The company pioneers the use of precision biology, combining genetics, gut microbiome analysis, and continuous glucose monitoring to tailor treatments for obesity, type 2 diabetes, gastrointestinal disorders, and mental health issues. Digbi's platform consolidates digital solutions for employers and provides personalized care for patients with multiple conditions. Recently, they launched a nationwide virtual clinic offering prescriptions for GLP drugs. Their services include personalized nutrition plans, weight management programs, digital health coaching, and food tolerance reports, all accessible via a mobile application and covered by insurance through employer partnerships.

Rosy Wellness

Seed Round in 2020
Rosy Wellness, Inc. is a company focused on sexual health and wellness for women, founded in 2018 and based in Dallas, Texas. It has developed an app-based platform that addresses decreased sexual desire by offering a comprehensive range of resources. The application includes educational videos, sexual health assessments, and a customizable library of romantic and sexy stories. Additionally, it features guided sessions with psychologists designed to help women explore and enhance their sexual wellness at their own pace. By providing a personalized wellness plan that incorporates evidence-based practices, Rosy Wellness aims to empower women to achieve their unique sexual health goals.

Folia Health

Convertible Note in 2020
Folia Health, Inc. is a Cambridge-based company that has developed an innovative web application designed for family caregivers to document and manage the daily observations of patients, particularly those with chronic conditions. Founded in 2016, Folia Health's platform allows caregivers to record health outcomes and share this critical information with healthcare teams during appointments, facilitating improved patient care. The application captures unique health data that reflects the patient's overall experience with disease and treatment, empowering caregivers and enhancing the understanding of disease burden. By focusing on patient-driven care and leveraging longitudinal data, Folia Health aims to support precision diagnostics and foster patient-centered drug development, contributing to a more effective and holistic approach to healthcare.

WholyMe

Seed Round in 2020
WholyMe Ltd, founded in 2018 and based in London, United Kingdom, specializes in producing natural relief products aimed at alleviating chronic pain and everyday stress. The company offers a range of all-natural and organic-certified wellness remedies, which include effective supplements and topical applications. WholyMe's products are free from preservatives, parabens, chemicals, and synthetics, providing customers with alternative solutions to conventional painkillers known for their adverse side effects. The focus on healthy, effective relief options reflects the company's commitment to delivering natural alternatives for pain management.

Breakthrough

Convertible Note in 2020
Breakthrough build privacy-focused applications that support people living with chronic disease and connect them to researchers.

AVA

Venture Round in 2019
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.

Rosy Wellness

Venture Round in 2019
Rosy Wellness, Inc. is a company focused on sexual health and wellness for women, founded in 2018 and based in Dallas, Texas. It has developed an app-based platform that addresses decreased sexual desire by offering a comprehensive range of resources. The application includes educational videos, sexual health assessments, and a customizable library of romantic and sexy stories. Additionally, it features guided sessions with psychologists designed to help women explore and enhance their sexual wellness at their own pace. By providing a personalized wellness plan that incorporates evidence-based practices, Rosy Wellness aims to empower women to achieve their unique sexual health goals.

Sigrid Therapeutics

Venture Round in 2019
Sigrid Therapeutics AB is a clinical-stage biotechnology company based in Stockholm, Sweden, focused on developing innovative therapeutic products aimed at preventing and treating lifestyle diseases. The company has created a novel materials platform designed to alter food digestion in the body. Its lead product is an ingested medical device intended to lower blood sugar levels in prediabetics, representing a new approach to managing chronic conditions related to modern lifestyles. By targeting the gut, Sigrid Therapeutics seeks to help individuals achieve weight loss and overall better health outcomes.

Pnoe

Seed Round in 2019
Pnoe is a company that specializes in developing a metabolic analysis device aimed at improving health and fitness outcomes. The device provides clinically accurate measurements of various physiological data, including metabolic, heart, lung, and cellular fitness. By utilizing breath analysis, Pnoe enables health professionals to prescribe personalized nutrition and training programs based on the specific needs of their clients. This innovative approach allows fitness professionals to identify limiting factors in an individual’s performance and tailor their recommendations accordingly. Recognized for its rapid growth, Pnoe was ranked as the 49th fastest growing company in the Americas for 2023 by the Financial Times.

Brainkey

Seed Round in 2019
Brainkey is a developer of a digital therapeutics platform focused on improving diagnosis and treatment of brain diseases. The company utilizes AI-derived brain biomarkers to provide personalized treatment recommendations, aiming to enhance brain longevity. By analyzing brain data at a petabyte scale, Brainkey's cloud-based technology facilitates informed clinical and pharmaceutical decision-making. This innovative approach enables patients and healthcare providers to access advanced brain care and analysis, ultimately transforming the landscape of brain disease management.

Epicore Biosystems

Seed Round in 2018
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.

Lark

Series B in 2018
Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.

Solarea Bio

Seed Round in 2018
Solarea Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbial therapeutics to address health disorders linked to chronic inflammation. Founded in 2017, the company utilizes a platform that combines microbial discovery and genomics to create synergistic microbial assemblages using bacteria and fungi derived from healthy foods. Solarea Bio generates an extensive database of complete genomic sequences of these microbes and employs computational approaches to formulate combinations that exhibit strong anti-inflammatory properties. The company's therapeutics aim to prevent or mitigate health issues associated with chronic inflammation, with initial applications targeting dietary management of metabolic conditions like osteopenia and osteoporosis in postmenopausal women. Through its innovative approach, Solarea Bio seeks to enhance the quality of life by providing nature-based solutions for various health challenges.

Ombre

Seed Round in 2018
Ombre is a company that specializes in microbiome testing, providing a testing kit that combines personalized probiotics with microbiome analysis. The company's offerings include subscription-based customized testing, which delivers science-backed probiotics tailored to individual needs. This approach aims to provide actionable insights for the prevention of chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By focusing on the root causes of gut health issues, Ombre enables customers to better understand and improve their microbiome, promoting overall wellness.

Flux Biosciences

Seed Round in 2018
Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.